Institute for Life Sciences and Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Building 85, Southampton SO17 1BJ, UK.
Centre for Immuno-oncology and CAMS-Oxford Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7BN, UK.
Curr Opin Immunol. 2023 Aug;83:102340. doi: 10.1016/j.coi.2023.102340. Epub 2023 May 26.
Which peptides are selected for presentation by major histocompatibility complex class-I (MHC-I) molecules is a key determinant of successful immune responses. Peptide selection is co-ordinated by the tapasin and TAP Binding PRotein (TAPBPR) proteins, which ensure MHC-I molecules preferentially acquire high-affinity-binding peptides. New structural analyses have offered insight into how tapasin achieves this function within the peptide-loading complex (PLC) (comprising the Transporter associated with Antigen Presentation (TAP) peptide transporter, tapasin-ERp57, MHC-I and calreticulin), and how TAPBPR performs a peptide editing function independently of other molecules. The new structures reveal nuances in how tapasin and TAPBPR interact with MHC-I, and how calreticulin and ERp57 complement tapasin to exploit the plasticity of MHC-I molecules to achieve peptide editing.
哪些肽被主要组织相容性复合体 I 类 (MHC-I) 分子呈递是成功免疫反应的关键决定因素。肽的选择由 tapasin 和 TAP 结合蛋白 (TAPBPR) 协调,这确保了 MHC-I 分子优先获得高亲和力结合的肽。新的结构分析提供了深入了解 tapasin 如何在肽加载复合物 (PLC)(包括抗原呈递相关转运体 (TAP) 肽转运体、tapasin-ERp57、MHC-I 和钙网蛋白)中发挥作用的机制,以及 TAPBPR 如何独立于其他分子发挥肽编辑功能。新结构揭示了 tapasin 和 TAPBPR 与 MHC-I 相互作用的细微差别,以及钙网蛋白和 ERp57 如何补充 tapasin 以利用 MHC-I 分子的可塑性来实现肽编辑。